Sphere Fluidics receives Queen’s Award for Enterprise for Innovation
Single-cell analysis for therapeutic discovery recognized with prestigious business award for innovation
Single-cell analysis for therapeutic discovery recognized with prestigious business award for innovation
Agilent Technologies, Thermo Fisher Scientific, and Tecan among those recognized
New automations in liquid biopsy research hold great promise for bringing us even closer to fully realizing its clinical utility in monitoring cancer from diagnosis through to remission
Discover a novel non-viral gene delivery system that could transform cell and gene therapy workflows
The NGSBIO Library Quant Kit contains all the components required for accurate and sensitive quantification of libraries prepared for for Illumina NGS systems.
Our LC-MS capabilities offer a flexible service from discovery, through to regulated GLP preclinical and GCP clinical studies.
Pkg of 1, 5% polyacrylamide gel, 18-well, 30 µl, 13.3 x 8.7 cm (W x L), for use with Criterion and Criterion Dodeca cells
Pkg of 1, 5% polyacrylamide gel, 26-well, 15 µl, 13.3 x 8.7 cm (W x L), for use with Criterion and Criterion Dodeca cells
QIAGEN becomes exclusive partner for bioinformatics research applications based on ARESdb and AREStools
New RNA-sequencing kit will improve treatment management decisions for breast cancer patients
Extended RAS Panel helps identify colorectal cancer patients eligible for Amgen’s Vectibix
Oncomine Cell-Free DNA Assay is designed to target and detect mutations down to 0.1 percent allele frequencies from whole blood derived from lung cancer tumors
Key opinion leaders’ expertise to guide design of new gene panels for GeneReader NGS
Adding solutions to QIAGEN Clinical Insight® for hereditary cancers and more somatic cancers
Educational workshops, new diagnostics platforms address critical factors for lab success